BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 12412534)

  • 1. HHS to study ephedra, step up enforcement against illegal marketing.
    FDA Consum; 2002; 36(5):3. PubMed ID: 12412534
    [No Abstract]   [Full Text] [Related]  

  • 2. Working to get ephedra banned.
    Consum Rep; 2003 Feb; 68(2):6. PubMed ID: 12516584
    [No Abstract]   [Full Text] [Related]  

  • 3. Medicine. Ephedra--scientific evidence versus money/politics.
    Wolfe SM
    Science; 2003 Apr; 300(5618):437. PubMed ID: 12702860
    [No Abstract]   [Full Text] [Related]  

  • 4. Ephedra-free is not danger-free.
    Marcus DM; Grollman AP
    Science; 2003 Sep; 301(5640):1669-71; author reply 1669-71. PubMed ID: 14500960
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA v. ephedra: is it time to lift the ban?
    Pyle KR
    Food Drug Law J; 2006; 61(4):701-51. PubMed ID: 17180770
    [No Abstract]   [Full Text] [Related]  

  • 6. More evidence supporting the ban of ephedra dietary supplements.
    Chavez ML
    Ann Pharmacother; 2004 May; 38(5):895-7. PubMed ID: 15044656
    [No Abstract]   [Full Text] [Related]  

  • 7. Natural-born killers.
    Mandavilli A
    Nat Med; 2003 Jun; 9(6):634-5. PubMed ID: 12778149
    [No Abstract]   [Full Text] [Related]  

  • 8. Developments in food and drug law.
    Masoudi GF
    Food Drug Law J; 2005; 60(2):107-16. PubMed ID: 16097088
    [No Abstract]   [Full Text] [Related]  

  • 9. The need for regulation of dietary supplements--lessons from ephedra.
    Fontanarosa PB; Rennie D; DeAngelis CD
    JAMA; 2003 Mar; 289(12):1568-70. PubMed ID: 12672775
    [No Abstract]   [Full Text] [Related]  

  • 10. Ephedra banned.
    Cockey CD
    AWHONN Lifelines; 2004; 8(1):19-25. PubMed ID: 15031882
    [No Abstract]   [Full Text] [Related]  

  • 11. [Ephedra products from the Internet: dangerous herb].
    Kaulen H
    Dtsch Med Wochenschr; 2004 Feb; 129(9):420. PubMed ID: 15017985
    [No Abstract]   [Full Text] [Related]  

  • 12. Ephedra ban: no shortage of reasons.
    Rados C
    FDA Consum; 2004; 38(2):6-7. PubMed ID: 15101356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ephedra: once a boon, now a bane.
    Scheindlin S
    Mol Interv; 2003 Oct; 3(7):358-60. PubMed ID: 14993455
    [No Abstract]   [Full Text] [Related]  

  • 14. Ephedra: yesterday, DSHEA, and tomorrow--a ten year perspective on the Dietary Supplement Health and Education Act of 1994.
    Seamon MJ; Clauson KA
    J Herb Pharmacother; 2005; 5(3):67-86. PubMed ID: 16520299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ephedra: heart dangers in disguise.
    Consum Rep; 2004 Jan; 69(1):22-3. PubMed ID: 14677546
    [No Abstract]   [Full Text] [Related]  

  • 16. Banning ephedra: good call, poor vision.
    Gordon JS
    Altern Ther Health Med; 2004; 10(6):18-9. PubMed ID: 15624346
    [No Abstract]   [Full Text] [Related]  

  • 17. Adverse events associated with supplements containing ephedra alkaloids.
    Geiger JD
    Clin J Sport Med; 2002 Jul; 12(4):263. PubMed ID: 12150162
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmaceutical industry restructuring and new marketing approaches: enforcement responses.
    Mahinka SP; Sanzo KM
    Food Drug Law J; 1995; 50(2):313-25. PubMed ID: 10343000
    [No Abstract]   [Full Text] [Related]  

  • 19. Legal ephedra?
    Consum Rep; 2010 Mar; 75(3):11. PubMed ID: 20358659
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiovascular effects of ephedra.
    Ness J
    JAMA; 2004 Apr; 291(13):1560; author reply 1560-1. PubMed ID: 15069037
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.